1-15 of 65
Leveraging CGM to Its Full Potential in People with T2D
CME/CELeveraging CGM to Its Full Potential in People with T2D
John E. Anderson, MD
Davida F. Kruger, CNP
DKA in Focus: What the New Consensus Means for Practice
CME/CEDKA in Focus: What the New Consensus Means for Practice
Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
Jennifer Sherr, MD, PhD
Applying Advances in Practice: Case-Based Look at Selecting Therapy for Cushing Syndrome
CME/CEApplying Advances in Practice: Case-Based Look at Selecting Therapy for Cushing Syndrome
Lewis S. Blevins, Jr, MD
James W. Suliburk, MD, FACS
Breaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026
CME/CEBreaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026
Deepak Bhatt, MD, MPH, MBA, FACC, FAHA
Amir H. Hamrahian, MD
No Patient with CKD Left Behind! Emerging CKD Therapies in T1D
CME/CENo Patient with CKD Left Behind! Emerging CKD Therapies in T1D
Richard E. Pratley, MD
David Cherney, MD, PhD
prof. Hiddo Heerspink
Advances in Treatment of Hypoparathyroidism: Importance of Genetic Testing for Autosomal Dominant Hypocalcemia Type 1
CME/CE Broadcast ReplayAdvances in Treatment of Hypoparathyroidism: Importance of Genetic Testing for Autosomal Dominant Hypocalcemia Type 1
Michael T. Collins, MD
- advertisement
The Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum
CME/CEThe Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum
prof. Hiddo Heerspink
Peter Rossing, MD, DMSc
Paola Fioretto, MD
Case-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKD
CME/CECase-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKD
Rajiv Agarwal, MBBS, MD, FASN, BRCU
Prof. Dr. Francesc Xavier Cos Claramunt
Global Perspectives on New Data in Type 2 Diabetes — Congress-to-Clinic Insights From ADA and EASD 2025
CME/CEGlobal Perspectives on New Data in Type 2 Diabetes — Congress-to-Clinic Insights From ADA and EASD 2025
Martin J. Abrahamson, MD, FACP, FRCP
Stefano Del Prato, MD
Linong Ji, MD
Risk Reduction with GLP-1 RAs in Individuals with ASCVD and T2D: 2025 Update
CME/CERisk Reduction with GLP-1 RAs in Individuals with ASCVD and T2D: 2025 Update
Brian P. McDonough, MD, FAAFP
Silvio Inzucchi, MD
Darren McGuire, MD, MHSc
Chairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
CME/CEChairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
Maria Fleseriu, MD, FACE
Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
CME/CEContinuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
Aristides Maniatis, MD
Kari Hosack
Meagan Broeckert
Sam Watson
- advertisement
Stemming the Tide on MASLD/MASH: It Starts on the Frontlines in Endocrinology and Primary Care Clinics
CME/CEStemming the Tide on MASLD/MASH: It Starts on the Frontlines in Endocrinology and Primary Care Clinics
Meena B. Bansal, MD, FAASLD
Nicholas Pennings, DO, DABOM, MFOMA, FACOFP, FAAFP
Fernando Bril, MD
Pam R. Taub, MD, FACC, FASPC
Kausik Ray, MBChB, MD, MPhil
Latest Clinical Trial Outcomes and Breakthroughs for FCS
MinuteCE®Latest Clinical Trial Outcomes and Breakthroughs for FCS
Daniel Gaudet, MD, PhD
Pam R. Taub, MD, FACC, FASPC
